Eupraxia Pharmaceuticals Price on June 3, 2024

EPRXFDelisted Stock  USD 2.79  0.04  1.45%   
If you're considering investing in Eupraxia Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Eupraxia Pharmaceuticals stands at 2.79, as last reported on the 29th of November, with the highest price reaching 2.83 and the lowest price hitting 2.66 during the day. We have found twenty-four technical indicators for Eupraxia Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm Eupraxia Pharmaceuticals' Mean Deviation of 2.65, standard deviation of 5.48, and Variance of 29.99 to check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Eupraxia Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
EPRXF
Based on monthly moving average Eupraxia Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Eupraxia Pharmaceuticals by adding Eupraxia Pharmaceuticals to a well-diversified portfolio.

Related Headline

MAIA Biotechnology Headline on 3rd of June 2024

MAIA Biotechnology Poster Marketscreener.com

Eupraxia Pharmaceuticals Valuation on June 3, 2024

It is possible to determine the worth of Eupraxia Pharmaceuticals on a given historical date. On June 3, 2024 Eupraxia was worth 2.7 at the beginning of the trading date compared to the closed value of 2.7. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Eupraxia Pharmaceuticals pink sheet. Still, in general, we apply an absolute valuation method to find Eupraxia Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Eupraxia Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Eupraxia Pharmaceuticals' related companies.
 Open High Low Close Volume
  2.72    2.87    2.71    2.71    9,416  
06/03/2024
  2.70    2.77    2.70    2.70    2,096  
  2.75    2.83    2.66    2.79    6,983  
Backtest Eupraxia Pharmaceuticals  |  Eupraxia Pharmaceuticals History  |  Eupraxia Pharmaceuticals Valuation   PreviousNext  
Open Value
2.7
2.7
Closing Value
2.70
Upside

Eupraxia Pharmaceuticals Trading Date Momentum on June 3, 2024

On June 04 2024 Eupraxia Pharmaceuticals was traded for  2.79  at the closing time. The highest daily price throughout the period was 2.83  and the lowest price was  2.66 . The daily volume was 7 K. The net trading volume on 06/04/2024 added to the next day price rise. The overall trading delta to closing price of the next trading day was 3.33% . The overall trading delta to current closing price is 1.85% .

Eupraxia Pharmaceuticals Fundamentals Correlations and Trends

By evaluating Eupraxia Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Eupraxia Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Eupraxia financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Eupraxia Pharmaceuticals Pink Sheet history

Eupraxia Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Eupraxia is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Eupraxia Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Eupraxia Pharmaceuticals stock prices may prove useful in developing a viable investing in Eupraxia Pharmaceuticals
Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012.Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada. Eupraxia Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 19 people.

Eupraxia Pharmaceuticals Pink Sheet Technical Analysis

Eupraxia Pharmaceuticals technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Eupraxia Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Eupraxia Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Eupraxia Pharmaceuticals Period Price Range

Low
November 29, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Eupraxia Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Eupraxia Pharmaceuticals November 29, 2024 Market Strength

Market strength indicators help investors to evaluate how Eupraxia Pharmaceuticals pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eupraxia Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Eupraxia Pharmaceuticals pink sheet market strength indicators, traders can identify Eupraxia Pharmaceuticals entry and exit signals to maximize returns

Eupraxia Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Eupraxia Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Eupraxia Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Eupraxia to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Eupraxia Pink Sheet

If you are still planning to invest in Eupraxia Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eupraxia Pharmaceuticals' history and understand the potential risks before investing.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Bonds Directory
Find actively traded corporate debentures issued by US companies
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios